PUBLICATION
Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.
- Authors
- Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honoré, C., Courtney, M., Huber, K.V., Schmitner, N., Kimmel, R.A., Romanov, R.A., Sturtzel, C., Lardeau, C.H., Klughammer, J., Farlik, M., Sdelci, S., Vieira, A., Avolio, F., Briand, F., Baburin, I., Májek, P., Pauler, F.M., Penz, T., Stukalov, A., Gridling, M., Parapatics, K., Barbieux, C., Berishvili, E., Spittler, A., Colinge, J., Bennett, K.L., Hering, S., Sulpice, T., Bock, C., Distel, M., Harkany, T., Meyer, D., Superti-Furga, G., Collombat, P., Hecksher-Sørensen, J., Kubicek, S.
- ID
- ZDB-PUB-161206-9
- Date
- 2017
- Source
- Cell 168(1-2): 86-100.e15 (Journal)
- Registered Authors
- Distel, Martin, Kimmel, Robin, Meyer, Dirk, Schmitner, Nicole, Sturtzel, Caterina
- Keywords
- ARX translocation, GABA-receptor signaling, artemisinins, chemical biology, diabetes, gephyrin, insulin secretion, pancreatic endocrine transdifferentiation, regenerative medicine, β cell
- MeSH Terms
-
- Disease Models, Animal*
- Mice
- Homeodomain Proteins/metabolism
- Islets of Langerhans/drug effects
- Receptors, GABA-A/metabolism*
- Transcription Factors/metabolism
- Single-Cell Analysis
- Rats
- Insulin/genetics
- Insulin/metabolism
- Cell Transdifferentiation/drug effects
- Signal Transduction*
- Gene Expression Profiling
- Carrier Proteins/metabolism
- Zebrafish
- Cells, Cultured
- Animals
- Protein Stability/drug effects
- Diabetes Mellitus/drug therapy
- Diabetes Mellitus, Type 1/drug therapy*
- Diabetes Mellitus, Type 1/pathology
- Humans
- Membrane Proteins/metabolism
- gamma-Aminobutyric Acid/metabolism
- Artemisinins/administration & dosage
- Artemisinins/pharmacology*
- PubMed
- 27916275 Full text @ Cell
Citation
Li, J., Casteels, T., Frogne, T., Ingvorsen, C., Honoré, C., Courtney, M., Huber, K.V., Schmitner, N., Kimmel, R.A., Romanov, R.A., Sturtzel, C., Lardeau, C.H., Klughammer, J., Farlik, M., Sdelci, S., Vieira, A., Avolio, F., Briand, F., Baburin, I., Májek, P., Pauler, F.M., Penz, T., Stukalov, A., Gridling, M., Parapatics, K., Barbieux, C., Berishvili, E., Spittler, A., Colinge, J., Bennett, K.L., Hering, S., Sulpice, T., Bock, C., Distel, M., Harkany, T., Meyer, D., Superti-Furga, G., Collombat, P., Hecksher-Sørensen, J., Kubicek, S. (2017) Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity.. Cell. 168(1-2):86-100.e15.
Abstract
Type 1 diabetes is characterized by the destruction of pancreatic β cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types, including glucagon-producing α cells. In a genetic model, loss of the master regulatory transcription factor Arx is sufficient to induce the conversion of α cells to functional β-like cells. Here, we identify artemisinins as small molecules that functionally repress Arx by causing its translocation to the cytoplasm. We show that the protein gephyrin is the mammalian target of these antimalarial drugs and that the mechanism of action of these molecules depends on the enhancement of GABAA receptor signaling. Our results in zebrafish, rodents, and primary human pancreatic islets identify gephyrin as a druggable target for the regeneration of pancreatic β cell mass from α cells.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping